Evidence map›Paper›PMID 29769672›Full record

ReviewNature2018

Pancreas regeneration.

Qiao Zhou, Douglas A Melton

Erratum issuedOpen access · greenAbstract readReview
In one paragraph

Review in Nature, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 201 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
201citing papers in PubMed, 2 pooled it
42.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

201 citing papers in PubMed, 2 syntheses or guidelines pooled it, 370 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Charting Endocrine Progenitors Across Species and Organs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Pancreatic injury induces β-cell regeneration in axolotl.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Streptozotocin induced hyperglycemia in the axolotl.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Article
  13. PVNJournal of neuroinflammation · 2026
    Article
  14. Article
  15. Pancreatic Exocrine Insufficiency Is Surprisingly Common.Integrative medicine (Encinitas, Calif.) · 2026
    Article
  16. Article
  17. Genetic recording of pancreatic beta cell proliferation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  18. Article
  19. Article
  20. Review

141 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Qiao ZhouDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. qiao_zhou@harvard.edu.
Douglas A MeltonDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. dmelton@harvard.edu.
Harvard University · US

Funding

Reprogram gastric tissue to functional insulin-secreting cellsR01DK106253 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI ZHOU, QIAO JOE · 2016 to 2020
$2.5M
Generating novel sources of functional human insulin-secreting cells for T1D modelingUC4DK116280 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI ZHOU, QIAO JOE · 2017 to 2017
$2.1M
Howard Hughes Medical InstituteNIDDK NIH HHS R01 DK106253NIDDK NIH HHS UC4 DK116280
6 · The paper itself

Abstract

The pancreas is made from two distinct components: the exocrine pancreas, a reservoir of digestive enzymes, and the endocrine islets, the source of the vital metabolic hormone insulin. Human islets possess limited regenerative ability; loss of islet β-cells in diseases such as type 1 diabetes requires therapeutic intervention. The leading strategy for restoration of β-cell mass is through the generation and transplantation of new β-cells derived from human pluripotent stem cells. Other approaches include stimulating endogenous β-cell proliferation, reprogramming non-β-cells to β-like cells, and harvesting islets from genetically engineered animals. Together these approaches form a rich pipeline of therapeutic development for pancreatic regeneration.

Indexed as

Adult Stem CellsAnimalsCell ProliferationCellular ReprogrammingHumansIslets of LangerhansPancreasPluripotent Stem CellsRegenerationRegenerative Medicine

Identifiers

PMID29769672
PMCPMC6168194
OpenAlexW4211070901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.